| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Escherichia coli O157 | 4 | 2019 | 26 | 2.71 | Why? |
| Thrombolytic Therapy | 12 | 2021 | 2218 | 1.48 | Why? |
| Bacterial Shedding | 3 | 2018 | 6 | 1.41 | Why? |
| Ultrasonography, Doppler, Transcranial | 7 | 2020 | 143 | 1.33 | Why? |
| Tissue Plasminogen Activator | 9 | 2019 | 778 | 1.29 | Why? |
| Escherichia coli Proteins | 3 | 2018 | 168 | 1.23 | Why? |
| Brain Ischemia | 14 | 2020 | 2813 | 1.17 | Why? |
| Escherichia coli Infections | 3 | 2018 | 348 | 1.17 | Why? |
| Fibrinolytic Agents | 9 | 2019 | 1702 | 1.15 | Why? |
| Headache | 5 | 2021 | 2257 | 1.10 | Why? |
| Respiratory Protective Devices | 3 | 2021 | 1637 | 1.10 | Why? |
| Middle Cerebral Artery | 4 | 2020 | 128 | 1.01 | Why? |
| Stroke | 20 | 2021 | 8839 | 0.89 | Why? |
| Symbolism | 1 | 2020 | 8 | 0.87 | Why? |
| Cerebrovascular Circulation | 3 | 2020 | 340 | 0.87 | Why? |
| Ischemic Attack, Transient | 5 | 2019 | 439 | 0.87 | Why? |
| Cerebral Revascularization | 1 | 2019 | 45 | 0.80 | Why? |
| Slit Lamp Microscopy | 1 | 2021 | 164 | 0.79 | Why? |
| Labetalol | 1 | 2018 | 13 | 0.78 | Why? |
| Escherichia coli Vaccines | 1 | 2018 | 7 | 0.75 | Why? |
| Food Microbiology | 1 | 2019 | 114 | 0.72 | Why? |
| Decompressive Craniectomy | 1 | 2018 | 72 | 0.70 | Why? |
| Mucormycosis | 3 | 2021 | 832 | 0.69 | Why? |
| Blepharoptosis | 1 | 2017 | 31 | 0.69 | Why? |
| Strabismus | 1 | 2017 | 34 | 0.67 | Why? |
| Carbon Dioxide | 2 | 2021 | 917 | 0.66 | Why? |
| Personal Protective Equipment | 5 | 2021 | 15978 | 0.65 | Why? |
| Antibodies, Bacterial | 2 | 2018 | 510 | 0.62 | Why? |
| Attitude to Health | 2 | 2021 | 2002 | 0.61 | Why? |
| Health Personnel | 9 | 2021 | 29646 | 0.61 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2018 | 203 | 0.59 | Why? |
| Virulence Factors | 1 | 2018 | 338 | 0.58 | Why? |
| Yoga | 1 | 2018 | 189 | 0.57 | Why? |
| Cerebral Infarction | 1 | 2017 | 245 | 0.54 | Why? |
| Multimodal Imaging | 1 | 2018 | 534 | 0.54 | Why? |
| Masks | 4 | 2021 | 8528 | 0.53 | Why? |
| Intracranial Embolism | 3 | 2019 | 73 | 0.51 | Why? |
| Hemodynamics | 2 | 2020 | 1562 | 0.51 | Why? |
| Blood Flow Velocity | 2 | 2020 | 193 | 0.50 | Why? |
| Singapore | 7 | 2020 | 3641 | 0.46 | Why? |
| Intracranial Arteriosclerosis | 3 | 2018 | 46 | 0.46 | Why? |
| Cattle Diseases | 4 | 2018 | 294 | 0.45 | Why? |
| Myasthenia Gravis | 1 | 2017 | 385 | 0.44 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.44 | Why? |
| Gene Knockout Techniques | 1 | 2011 | 347 | 0.41 | Why? |
| Bacterial Vaccines | 1 | 2011 | 139 | 0.40 | Why? |
| Perception | 1 | 2021 | 2827 | 0.39 | Why? |
| Antihypertensive Agents | 2 | 2019 | 1962 | 0.39 | Why? |
| DNA-Binding Proteins | 1 | 2011 | 469 | 0.35 | Why? |
| Cattle | 4 | 2018 | 1336 | 0.35 | Why? |
| Acclimatization | 2 | 2018 | 69 | 0.35 | Why? |
| Tilt-Table Test | 1 | 2007 | 20 | 0.35 | Why? |
| Feces | 3 | 2018 | 4235 | 0.35 | Why? |
| Cerebral Hemorrhage | 5 | 2018 | 820 | 0.34 | Why? |
| Cerebral Angiography | 4 | 2019 | 391 | 0.33 | Why? |
| Macrophages | 2 | 2019 | 2784 | 0.32 | Why? |
| Stress Disorders, Post-Traumatic | 2 | 2020 | 2963 | 0.32 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.32 | Why? |
| Infusions, Intravenous | 3 | 2019 | 1224 | 0.30 | Why? |
| Administration, Intravenous | 6 | 2018 | 1115 | 0.29 | Why? |
| Occupational Diseases | 1 | 2020 | 2787 | 0.28 | Why? |
| Sinus Thrombosis, Intracranial | 2 | 2021 | 550 | 0.28 | Why? |
| Altitude | 2 | 2018 | 311 | 0.27 | Why? |
| Observational Studies as Topic | 4 | 2020 | 1887 | 0.26 | Why? |
| Parents | 1 | 2017 | 2758 | 0.25 | Why? |
| Intracranial Hemorrhages | 4 | 2021 | 1170 | 0.25 | Why? |
| Carotid Artery, Internal | 2 | 2019 | 97 | 0.23 | Why? |
| Autonomic Nervous System | 2 | 2018 | 148 | 0.23 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 1510 | 0.23 | Why? |
| Recovery of Function | 4 | 2020 | 2461 | 0.22 | Why? |
| Treatment Outcome | 17 | 2021 | 51732 | 0.22 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.22 | Why? |
| Homocysteine | 2 | 2018 | 83 | 0.22 | Why? |
| Lethargy | 1 | 2020 | 55 | 0.21 | Why? |
| Constriction, Pathologic | 2 | 2019 | 212 | 0.21 | Why? |
| Humans | 57 | 2021 | 930598 | 0.21 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.21 | Why? |
| Pulsatile Flow | 1 | 2020 | 123 | 0.21 | Why? |
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 8 | 0.20 | Why? |
| Operon | 1 | 2019 | 12 | 0.20 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.20 | Why? |
| Genomic Islands | 1 | 2019 | 26 | 0.20 | Why? |
| Computed Tomography Angiography | 3 | 2019 | 2153 | 0.20 | Why? |
| Chromosomes, Bacterial | 1 | 2019 | 18 | 0.20 | Why? |
| Hypercapnia | 1 | 2021 | 172 | 0.20 | Why? |
| Temporal Arteries | 1 | 2019 | 35 | 0.20 | Why? |
| Stress, Psychological | 2 | 2020 | 10231 | 0.20 | Why? |
| Comprehensive Health Care | 1 | 2020 | 153 | 0.20 | Why? |
| Time Factors | 12 | 2021 | 31397 | 0.19 | Why? |
| Male | 35 | 2021 | 367725 | 0.19 | Why? |
| Cerebral Arterial Diseases | 1 | 2019 | 46 | 0.19 | Why? |
| Endophytes | 1 | 2018 | 16 | 0.19 | Why? |
| Bison | 1 | 2018 | 1 | 0.19 | Why? |
| DNA Transposable Elements | 1 | 2019 | 91 | 0.19 | Why? |
| India | 4 | 2021 | 11875 | 0.19 | Why? |
| Intracranial Hemorrhage, Hypertensive | 1 | 2018 | 4 | 0.19 | Why? |
| Adaptation, Psychological | 1 | 2017 | 4996 | 0.19 | Why? |
| Depression | 2 | 2020 | 14116 | 0.19 | Why? |
| Allied Health Personnel | 2 | 2020 | 416 | 0.18 | Why? |
| Aphasia | 1 | 2018 | 33 | 0.18 | Why? |
| Receptors, Pattern Recognition | 1 | 2019 | 128 | 0.18 | Why? |
| Weaning | 1 | 2018 | 46 | 0.18 | Why? |
| Hematoma, Subdural | 1 | 2018 | 36 | 0.18 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2018 | 60 | 0.18 | Why? |
| Female | 33 | 2021 | 380317 | 0.18 | Why? |
| Soil Pollutants | 1 | 2018 | 57 | 0.18 | Why? |
| Ruminants | 1 | 2018 | 52 | 0.18 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.18 | Why? |
| Functional Laterality | 1 | 2018 | 57 | 0.18 | Why? |
| Disability Evaluation | 2 | 2019 | 671 | 0.18 | Why? |
| Brain Infarction | 1 | 2019 | 129 | 0.18 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.18 | Why? |
| Lamiaceae | 1 | 2017 | 29 | 0.18 | Why? |
| Adult | 21 | 2021 | 244371 | 0.17 | Why? |
| Lead | 1 | 2018 | 94 | 0.17 | Why? |
| Pseudophakia | 1 | 2016 | 7 | 0.17 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.17 | Why? |
| Basidiomycota | 1 | 2017 | 42 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.17 | Why? |
| Delivery of Health Care, Integrated | 2 | 2020 | 1549 | 0.17 | Why? |
| Brain-Derived Neurotrophic Factor | 1 | 2018 | 133 | 0.17 | Why? |
| Lenses, Intraocular | 1 | 2016 | 15 | 0.17 | Why? |
| Mycobiome | 1 | 2017 | 43 | 0.17 | Why? |
| Foodborne Diseases | 1 | 2018 | 89 | 0.17 | Why? |
| Anxiety | 2 | 2020 | 17311 | 0.17 | Why? |
| Carotid Arteries | 1 | 2018 | 182 | 0.16 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.16 | Why? |
| Immunization, Secondary | 2 | 2018 | 1649 | 0.16 | Why? |
| Arteries | 1 | 2019 | 283 | 0.16 | Why? |
| Brain | 3 | 2018 | 5133 | 0.16 | Why? |
| Ascomycota | 1 | 2017 | 71 | 0.16 | Why? |
| Telemetry | 1 | 2019 | 240 | 0.16 | Why? |
| Platelet Aggregation Inhibitors | 2 | 2017 | 1671 | 0.16 | Why? |
| Carotid Stenosis | 1 | 2019 | 207 | 0.16 | Why? |
| Bacteriophages | 1 | 2019 | 268 | 0.15 | Why? |
| Carotid Artery Diseases | 1 | 2019 | 251 | 0.15 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.15 | Why? |
| Protein-Tyrosine Kinases | 1 | 2017 | 158 | 0.15 | Why? |
| Enterocytes | 1 | 2018 | 245 | 0.15 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.15 | Why? |
| Genome, Bacterial | 1 | 2019 | 446 | 0.15 | Why? |
| Lymphoma, B-Cell | 1 | 2017 | 166 | 0.15 | Why? |
| Surveys and Questionnaires | 5 | 2021 | 43792 | 0.15 | Why? |
| Monitoring, Ambulatory | 1 | 2019 | 343 | 0.14 | Why? |
| Textiles | 1 | 2020 | 458 | 0.14 | Why? |
| Vitamin K | 1 | 2017 | 263 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.14 | Why? |
| Vascular Calcification | 1 | 2019 | 396 | 0.14 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.14 | Why? |
| Silver | 1 | 2017 | 327 | 0.14 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.14 | Why? |
| Cross-Sectional Studies | 6 | 2021 | 53120 | 0.13 | Why? |
| Microvessels | 1 | 2018 | 490 | 0.13 | Why? |
| Mood Disorders | 1 | 2018 | 431 | 0.13 | Why? |
| Prospective Studies | 11 | 2021 | 43301 | 0.13 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.13 | Why? |
| Asia | 1 | 2021 | 2399 | 0.13 | Why? |
| Lymphoma, Non-Hodgkin | 1 | 2017 | 403 | 0.13 | Why? |
| Myopia | 1 | 2016 | 189 | 0.13 | Why? |
| Ultrasonic Therapy | 1 | 2013 | 43 | 0.13 | Why? |
| Gold | 1 | 2017 | 592 | 0.13 | Why? |
| Immunity, Herd | 1 | 2021 | 1011 | 0.12 | Why? |
| Heart Rate | 2 | 2019 | 1527 | 0.12 | Why? |
| Thrombectomy | 2 | 2021 | 2272 | 0.12 | Why? |
| Time-to-Treatment | 3 | 2020 | 5883 | 0.12 | Why? |
| Cognition Disorders | 1 | 2018 | 574 | 0.12 | Why? |
| Respiration | 1 | 2018 | 729 | 0.12 | Why? |
| Equipment Reuse | 1 | 2020 | 985 | 0.12 | Why? |
| Mechanical Thrombolysis | 1 | 2013 | 150 | 0.12 | Why? |
| Social Stigma | 1 | 2021 | 1049 | 0.11 | Why? |
| Environment | 1 | 2018 | 769 | 0.11 | Why? |
| Angiography, Digital Subtraction | 1 | 2011 | 123 | 0.11 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.11 | Why? |
| Prevalence | 5 | 2020 | 25773 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Risk Factors | 10 | 2020 | 71621 | 0.11 | Why? |
| Zinc | 1 | 2018 | 817 | 0.11 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.11 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.10 | Why? |
| Clinical Protocols | 2 | 2018 | 2734 | 0.10 | Why? |
| Intracranial Aneurysm | 1 | 2015 | 504 | 0.10 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.10 | Why? |
| Salmonella Infections, Animal | 1 | 2009 | 18 | 0.10 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.09 | Why? |
| Salmonella typhimurium | 1 | 2009 | 81 | 0.09 | Why? |
| Graft Rejection | 1 | 2019 | 1766 | 0.09 | Why? |
| Injections, Intramuscular | 1 | 2011 | 800 | 0.09 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.09 | Why? |
| Ultrasonography, Interventional | 1 | 2013 | 560 | 0.09 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 1692 | 0.09 | Why? |
| Vasomotor System | 1 | 2007 | 13 | 0.09 | Why? |
| Atrial Fibrillation | 2 | 2019 | 2320 | 0.09 | Why? |
| Phosphoproteins | 1 | 2018 | 4346 | 0.08 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Patient Positioning | 1 | 2018 | 1505 | 0.08 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.08 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.08 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Basilar Artery | 2 | 2019 | 31 | 0.08 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.08 | Why? |
| Intestinal Diseases | 1 | 2009 | 231 | 0.08 | Why? |
| Venous Thrombosis | 1 | 2021 | 2739 | 0.07 | Why? |
| Vaccines, Attenuated | 1 | 2011 | 952 | 0.07 | Why? |
| Aged | 19 | 2021 | 215776 | 0.07 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.07 | Why? |
| Cell Line | 2 | 2018 | 12040 | 0.07 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.07 | Why? |
| Magnetic Resonance Angiography | 2 | 2017 | 282 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Nurses | 1 | 2020 | 2285 | 0.07 | Why? |
| Animals | 5 | 2018 | 78931 | 0.07 | Why? |
| Tomography, X-Ray Computed | 4 | 2018 | 25144 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Zoonoses | 1 | 2018 | 3034 | 0.07 | Why? |
| Homeostasis | 1 | 2007 | 582 | 0.06 | Why? |
| Tertiary Care Centers | 5 | 2020 | 8248 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Odds Ratio | 3 | 2021 | 5861 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.06 | Why? |
| B-Lymphocytes | 1 | 2017 | 4418 | 0.06 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.06 | Why? |
| T-Lymphocytes | 1 | 2019 | 6670 | 0.06 | Why? |
| Escherichia coli | 1 | 2009 | 1547 | 0.05 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Vertebral Artery | 1 | 2019 | 52 | 0.05 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.05 | Why? |
| Neuroimaging | 2 | 2019 | 1106 | 0.05 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.05 | Why? |
| Kidney Transplantation | 1 | 2019 | 5397 | 0.05 | Why? |
| Aged, 80 and over | 6 | 2018 | 88759 | 0.05 | Why? |
| Pulse | 1 | 2018 | 37 | 0.05 | Why? |
| Chaetomium | 1 | 2017 | 3 | 0.05 | Why? |
| Silver Nitrate | 1 | 2017 | 10 | 0.05 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.04 | Why? |
| Metabolic Networks and Pathways | 1 | 2019 | 285 | 0.04 | Why? |
| Scleral Buckling | 1 | 2016 | 23 | 0.04 | Why? |
| Retrospective Studies | 5 | 2020 | 105322 | 0.04 | Why? |
| Databases, Bibliographic | 1 | 2017 | 182 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2019 | 757 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.04 | Why? |
| Surface Properties | 1 | 2017 | 448 | 0.04 | Why? |
| Alberta | 1 | 2017 | 375 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Quinazolinones | 1 | 2017 | 135 | 0.04 | Why? |
| Anticoagulants | 1 | 2017 | 9563 | 0.04 | Why? |
| Allografts | 1 | 2019 | 761 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Patient Care Team | 2 | 2020 | 3556 | 0.04 | Why? |
| Biodiversity | 1 | 2018 | 546 | 0.04 | Why? |
| Neurologic Examination | 1 | 2018 | 428 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.04 | Why? |
| Neurologists | 1 | 2018 | 283 | 0.03 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.03 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2017 | 424 | 0.03 | Why? |
| Retinal Detachment | 1 | 2016 | 146 | 0.03 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Adenine | 1 | 2017 | 463 | 0.03 | Why? |
| International Cooperation | 2 | 2021 | 3436 | 0.03 | Why? |
| Prosthesis Design | 1 | 2016 | 594 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2018 | 21571 | 0.03 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Health Expenditures | 1 | 2021 | 904 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Disease Models, Animal | 1 | 2011 | 10998 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Psychotherapy | 1 | 2020 | 747 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Endovascular Procedures | 1 | 2021 | 1302 | 0.03 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.03 | Why? |
| Purines | 1 | 2017 | 816 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Biomarkers | 3 | 2019 | 23361 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.03 | Why? |
| Antifungal Agents | 1 | 2021 | 1828 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Dendritic Cells | 1 | 2019 | 1330 | 0.03 | Why? |
| Greece | 1 | 2017 | 2091 | 0.03 | Why? |
| Biopsy | 1 | 2019 | 2811 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2013 | 1008 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| Hand Hygiene | 1 | 2020 | 1493 | 0.02 | Why? |
| Diabetes Complications | 1 | 2021 | 2358 | 0.02 | Why? |
| Pyrimidines | 1 | 2017 | 1557 | 0.02 | Why? |
| Ventilators, Mechanical | 1 | 2021 | 2193 | 0.02 | Why? |
| Colony Count, Microbial | 1 | 2009 | 177 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2017 | 2886 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Meta-Analysis as Topic | 1 | 2015 | 1289 | 0.02 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.02 | Why? |
| Registries | 2 | 2019 | 12327 | 0.02 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.02 | Why? |
| Animals, Newborn | 1 | 2009 | 350 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2019 | 3788 | 0.02 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Pyrazoles | 1 | 2017 | 1791 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.02 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| DNA, Bacterial | 1 | 2009 | 835 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.02 | Why? |
| Referral and Consultation | 1 | 2020 | 4816 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2013 | 3395 | 0.02 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.02 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.01 | Why? |
| Hemorrhage | 1 | 2013 | 3013 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Postoperative Complications | 1 | 2016 | 5861 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Carrier State | 1 | 2009 | 2100 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2009 | 6740 | 0.01 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.01 | Why? |
| Cohort Studies | 1 | 2015 | 36005 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2011 | 22971 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |